The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a ...
The drug anastrozole is effective in treating an early form of breast cancer, according to a clinical trial led by Queen Mary University of London (QMUL). The results of the IBIS-II DCIS trial show ...
Phase I and Pharmacokinetic Study of Imatinib Mesylate in Patients With Advanced Malignancies and Varying Degrees of Liver Dysfunction: A Study by the National Cancer Institute Organ Dysfunction ...
Anastrozole, an aromatase inhibitor, is widely prescribed for oestrogen receptor-positive breast cancer. Although effective, it has been linked to autoimmune hepatitis (AIH), a rare but serious ...
Post-menopausal women in the UK who are at a higher risk of breast cancer may soon have wider access to a medicine called anastrozole to reduce their chance of developing it. The drug, which is taken ...
Comparison of the Efficacy of Local Therapies for Localized Prostate Cancer in the Prostate-Specific Antigen Era: A Large Single-Institution Experience With Radical Prostatectomy and External-Beam ...
A new study published in The Lancet Oncology discusses the efficacy of anastrozole, a molecule used to prevent breast cancer in postmenopausal women with a high risk of breast cancer. Study: Effect of ...
CHICAGO, Dec 14 (Reuters) - Women who took AstraZeneca Plc's breast cancer drug Arimidex fared better than those who took the pill tamoxifen even four years after they stopped taking it, researchers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback